Biosensor developments: application to prostate-specific antigen detection

Trends in Biotechnology

Volumn 25, Issue 3, 2007, Pages 125-131

  Healy, Declan A ^a   Hayes, Conor J ^a   Leonard, Paul ^a   McKenna, Louise ^b   O'Kennedy, Richard ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b Forensic Science Laboratory Dulin Ireland   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; BIOASSAY; BIOMARKERS; PATIENT MONITORING; TUMORS;

AZOOSPERMIC SEMEN; BIOSENSOR DETECTION; FORENSIC MARKERS; PROSTATE SPECIFIC ANTIGEN (PSA);

BIOSENSORS;

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; AZOOSPERMIA; BIOSENSOR; CANCER DIAGNOSIS; FLUORESCENCE; FORENSIC MEDICINE; PRIORITY JOURNAL; PROSTATE CANCER; RAMAN SPECTROMETRY; REVIEW; SEMEN ANALYSIS; SEXUAL CRIME; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

BIOSENSING TECHNIQUES; FEMALE; FORENSIC MEDICINE; HUMANS; IMMUNOASSAY; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 33847188843     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2007.01.004     Document Type: Review

References (50)

1. Ozen H., and Sozen S. PSA isoforms in prostate cancer detection. Eur. Urol. Suppl. 5 (2006) 495
2. Aus G., et al. EAU guidelines on prostate cancer. Eur. Urol. 48 (2005) 546-551
3. Zhu Y., et al. Computer technology in detection and staging of prostate carcinoma: a review. Med. Image Anal. 10 (2006) 178-199
4. Saad F. The treatment continuum in the management of prostate cancer patients: what's new?. Eur. Urol. Suppl. 5 (2006) 539
5. Nadler R.B., et al. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate-specific antigen levels. J. Urol. 154 (1995) 407-413
6. Stenman U.H., et al. Prostate-specific antigen. Semin. Cancer Biol. 9 (1999) 83-93
7. Roddam A.W., et al. Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: systematic review and meta-analysis. Eur. Urol. 48 (2005) 386-399
8. Catalona W.J., et al. Serum pro-prostate-specific antigen improves cancer detection compared to free and complexed prostate-specific antigen in men with prostate-specific antigen of 2 to 4 ng/ml. J. Urol. 170 (2003) 2181-2185
9. Linton H.J., et al. Benign prostate-specific antigen (BPSA) in serum is increased in benign prostate disease. Clin. Chem. 49 (2003) 253-259
10. Mikolajczyk S.D., et al. Are multiple markers the future of prostate cancer diagnostics?. Clin. Biochem. 37 (2004) 519-528
11. Johnson E.D., and Kotowski T.M. Detection of prostate-specific antigen by ELISA. J. Forensic Sci. 38 (1993) 250-258
12. Kost G.J. Guidelines for point-of-care testing. Improving patient outcomes. Am. J. Clin. Pathol. 104 (1995) S111-S127
13. Grieve R., et al. Near-patient testing in diabetes clinics: appraising the costs and outcomes. Health Technol. Assess. 3 (1999) 1-74
14. Yokota M., et al. Evaluation of prostate-specific antigen (PSA) membrane test for forensic examination of semen. Leg. Med. (Tokyo) 3 (2001) 171-176
15. Khaldi N., et al. Evaluation of three rapid detection methods for the forensic identification of seminal fluid in rape cases. J. Forensic Sci. 49 (2004) 749-753
16. Hochmeister M.N., et al. Evaluation of prostate-specific antigen (PSA) membrane test assays for the forensic identification of seminal fluid. J. Forensic Sci. 44 (1999) 1057-1060
17. Soukka T., et al. Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology. Clin. Chem. 47 (2001) 1269-1278
18. Ye Z., et al. Preparation, characterization and time-resolved fluorometric application of silica-coated terbium(III) fluorescent nanoparticles. Anal. Chem. 76 (2004) 513-518
19. Huhtinen P., et al. Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology. J. Immunol. Methods 294 (2004) 111-122
20. Ye Z., et al. Preparation, characterization and application of fluorescent terbium-complex-doped zirconia nanoparticles. J. Fluoresc. 15 (2005) 499-505
21. Grubisha D.S., et al. Femtomolar detection of prostate-specific antigen: an immunoassay based on surface-enhanced Raman scattering and immunogold labels. Anal. Chem. 75 (2003) 5936-5943
22. Ni J., et al. Immunoassay readout method using extrinsic Raman labels adsorbed on immunogold colloids. Anal. Chem. 71 (1999) 4903-4908
23. Sano T., et al. Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. Science 258 (1992) 120-122
24. Lind K., and Kubista M. Development and evaluation of three real-time immuno-PCR assemblages for quantification of PSA. J. Immunol. Methods 304 (2005) 107-116
25. Schweitzer B., et al. Inaugural article: immunoassays with rolling circle DNA amplification: a versatile platform for ultrasensitive antigen detection. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 10113-10119
26. Nam J.M., et al. Nanoparticle-based bio-barcodes for the ultrasensitive detection of proteins. Science 301 (2003) 1884-1886
27. Bao Y.P., et al. Detection of protein analytes via nanoparticle-based bio-barcode technology. Anal. Chem. 78 (2006) 2055-2059
28. Wang J. Electrochemical biosensors: towards point-of-care cancer diagnostics. Biosens. Bioelectron. 21 (2006) 1887-1892
29. Fernandez-Sanchez C., et al. Disposable noncompetitive immunosensor for free and total prostate-specific antigen based on capacitance measurement. Anal. Chem. 76 (2004) 5649-5656
30. Meyerhoff M.E., et al. Novel non-separation sandwich-type electrochemical enzyme immunoassay system for detecting marker proteins in undiluted blood. Clin. Chem. 41 (1995) 1378-1384
31. Sarkar P., et al. Amperometric biosensors for detection of the prostate cancer marker (PSA). Int. J. Pharm. 238 (2002) 1-9
32. Kojima K., et al. Electrochemical protein chip with arrayed immunosensors with antibodies immobilized in a plasma-polymerized film. Anal. Chem. 75 (2003) 1116-1122
33. Wilson W.D. Tech. Sight. Analyzing biomolecular interactions. Science 295 (2002) 2103-2105
34. Huang L., et al. Prostate-specific antigen immunosensing based on mixed self-assembled monolayers, camel antibodies and colloidal-gold enhanced sandwich assays. Biosens. Bioelectron. 21 (2005) 483-490
35. Cao C., et al. A strategy for sensitivity and specificity enhancements in prostate-specific antigen-alpha-1-anti-chymotrypsin detection based on surface plasmon resonance. Biosens. Bioelectron. 21 (2006) 2106-2113
36. Nath N., and Chilkoti A. Label-free colorimetric biosensing using nanoparticles. J. Fluoresc. 14 (2004) 377-389
37. Nicewarner-Pena S.R., et al. Submicrometer metallic barcodes. Science 294 (2001) 137-141
38. Lee J.H., et al. Immunoassay of prostate-specific antigen (PSA) using resonant frequency shift of piezoelectric nanomechanical microcantilever. Biosens. Bioelectron. 20 (2005) 2157-2162
39. Hwang K.S., et al. In situ quantitative analysis of a prostate-specific antigen (PSA) using a nanomechanical PZT cantilever. Lab Chip 4 (2004) 547-552
40. Wee K.W., et al. Novel electrical detection of label-free disease marker proteins using piezoresistive self-sensing micro-cantilevers. Biosens. Bioelectron. 20 (2005) 1932-1938
41. McKendry R., et al. Multiple label-free biodetection and quantitative DNA-binding assays on a nanomechanical cantilever array. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9783-9788
42. Zheng G., et al. Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat. Biotechnol. 23 (2005) 1294-1301
43. Lein M., et al. Rapid screening of PSA: evaluation of an immunochemical membrane strip test. Clin. Chem. 41 (1995) 1545-1547
44. Jung K., et al. Rapid detection of elevated prostate-specific antigen levels in blood: performance of various membrane strip tests compared. Urology 53 (1999) 155-160
45. Oberpenning F., et al. Semi-quantitative immunochromatographic test for prostate-specific antigen in whole blood: tossing the coin to predict prostate cancer?. Eur. Urol. 43 (2003) 478-484
46. Madersbacher S., et al. Validation of a 10-minute dipstick test for serum prostate-specific antigen. Eur. Urol. 30 (1996) 446-450
47. Berg W., et al. Possibility of improving the acceptance rate of early detection testing for prostate cancer with a one-step test for prostate-specific antigen in whole blood. Urol. Int. 63 (1999) 102-106
48. Soukka T., et al. Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology. Clin. Chim. Acta 328 (2003) 45-58
49. Besselink G.A., et al. Signal amplification on planar and gel-type sensor surfaces in surface plasmon resonance-based detection of prostate-specific antigen. Anal. Biochem. 333 (2004) 165-173
50. Yu F., et al. Surface plasmon fluorescence immunoassay of free prostate-specific antigen in human plasma at the femtomolar level. Anal. Chem. 76 (2004) 6765-6770